Retatrutide

Description

First-in-class triple receptor agonist (GLP-1/GIP/glucagon). a leading subject of current metabolic research.

Mechanism

First-in-class triple receptor agonist (GLP-1, GIP, glucagon). drives energy expenditure alongside appetite modulation.

Research applications

• Advanced metabolic research
• Energy expenditure studies

Specifications

• Purity: 99.6% (HPLC / MS verified)
• Vial size: 5mg
• Available sizes: 5mg, 10mg, 15mg, 20mg, 30mg
• Form: Lyophilized powder
• Storage: -20°C, protect from light

For laboratory research use only. Not for human or veterinary use. Lot-matched Certificate of Analysis included with every order.